Skip to main content
Equibles
NRIX logo

NRIX · Nurix Therapeutics, Inc.

Track NRIX — free

Use NRIX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about NRIX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$27.18 +0.13 (+0.48%)
Market Cap
$2.88B
Shares
103.78M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.

Funds holding NRIX

199 fund positions
Fund Balance Value % of Fund Open
VANGUARD TOTAL STOCK MARKET INDEX FUND 3,231,112 $50,082,236 0.00%
State Street(R) SPDR(R) S&P(R) Biotech ETF 2,809,877 $43,553,094 0.59%
iShares Russell 2000 ETF 2,477,638 $38,403,389 0.05%
ARK Genomic Revolution ETF 1,723,734 $28,786,358 2.33%
Eventide Healthcare & Life Sciences Fund 1,297,893 $20,117,342 1.27%
T. Rowe Price Health Sciences Fund, Inc. 1,215,025 $18,832,888 0.17%
Fidelity Small Cap Index Fund 1,004,939 $16,782,481 0.05%
VANGUARD EXTENDED MARKET INDEX FUND 1,077,591 $16,702,661 0.02%
Fidelity Small Cap Growth Fund 948,302 $15,836,643 0.19%
SMALLCAP World Fund Inc 893,327 $13,846,569 0.02%
iShares Russell 2000 Value ETF 870,755 $13,496,703 0.11%
Fidelity Growth Company Fund 646,065 $11,474,114 0.01%
iShares Biotechnology ETF 720,848 $11,173,144 0.14%
VANGUARD RUSSELL 2000 INDEX FUND 522,443 $9,278,588 0.05%
Fidelity Extended Market Index Fund 500,542 $8,889,626 0.02%
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund 546,254 $8,466,937 0.10%
Schwab U.S. Small-Cap ETF 466,104 $8,278,007 0.04%
Fidelity Small Cap Growth K6 Fund 475,558 $7,941,819 0.19%
Select Biotechnology Portfolio 333,346 $5,920,225 0.11%
T. Rowe Price New Horizons Fund, Inc. 355,556 $5,511,118 0.04%
Nuveen Quant Small/Mid Cap Equity Fund 314,940 $5,259,498 0.20%
Strategic Advisers Fidelity U.S. Total Stock Fund 284,593 $5,054,372 0.00%
Dimensional U.S. Small Cap ETF 262,252 $4,379,608 0.03%
Fidelity Series Small Cap Core Fund 246,100 $4,109,870 0.25%
VANGUARD HEALTH CARE INDEX FUND 228,970 $4,066,507 0.02%
iShares Micro-Cap ETF 256,256 $3,971,968 0.33%
College Retirement Equities Fund - Total Global Stock Account 255,300 $3,957,150 0.00%
U.S. MICRO CAP PORTFOLIO 230,587 $3,850,803 0.05%
Schwab Small-Cap Index Fund 222,422 $3,714,447 0.05%
First Trust Small Cap Growth AlphaDEX Fund 221,752 $3,703,258 0.35%
Fidelity Total Market Index Fund 182,446 $3,240,241 0.00%
VANGUARD STRATEGIC SMALL-CAP EQUITY FUND 199,602 $3,093,831 0.13%
Fidelity Growth Company K6 Fund 161,607 $2,870,140 0.01%
Fidelity Small Cap Discovery Fund 171,800 $2,869,060 0.13%
Direxion Daily S&P Biotech Bull 3X Shares 160,937 $2,687,648 0.52%
Fidelity Series Total Market Index Fund 147,305 $2,616,137 0.00%
Master Small Cap Index Series 164,620 $2,551,610 0.05%
Fidelity Series Small Cap Discovery Fund 147,400 $2,461,580 0.13%
iShares U.S. Small-Cap Equity Factor ETF 131,042 $2,188,401 0.06%
U.S. SMALL CAP PORTFOLIO 126,728 $2,116,358 0.01%
Fidelity Series Growth Company Fund 117,800 $2,092,128 0.01%
Invesco RAFI US 1500 Small-Mid ETF 122,970 $2,053,599 0.07%
iShares Core S&P Total U.S. Stock Market ETF 131,972 $2,045,566 0.00%
Nuveen Small Cap Blend Index Fund 121,865 $2,035,146 0.05%
Goldman Sachs Small Cap Value Insights Fund 120,528 $2,012,818 0.18%
BlackRock Advantage Small Cap Core Fund 112,606 $1,999,883 0.04%
Fidelity Small Cap Value Index Fund 125,835 $1,950,443 0.11%
Dimensional U.S. Core Equity 2 ETF 116,360 $1,943,212 0.00%
EQ/2000 Managed Volatility Portfolio 108,040 $1,674,620 0.05%
LVIP State Street Small-Cap Index Fund 66,600 $1,615,716 0.07%
Showing 1–50 of 199 positions
Key facts CIK 1549595 CUSIP 67080M103 13F (30d) 208 filings 201 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)